GPX7 and astrocytoma (excluding glioblastoma): Notably, in both cohorts, GPX7 was prominently higher in GBM than in LGG tumors (Oligoastrocytoma; Oligodendroglioma; Astrocytoma), while the expression of GPX7 was significantly higher as pathological grade increased (Fig. 2a–d).